CRLBF
Price
$1.03
Change
-$0.02 (-1.90%)
Updated
Sep 26 closing price
Capitalization
362.14M
40 days until earnings call
PLNH
Price
$0.21
Change
-$0.01 (-4.55%)
Updated
Sep 26 closing price
Capitalization
68.84M
Interact to see
Advertisement

CRLBF vs PLNH

Header iconCRLBF vs PLNH Comparison
Open Charts CRLBF vs PLNHBanner chart's image
Cresco Labs
Price$1.03
Change-$0.02 (-1.90%)
Volume$600.85K
Capitalization362.14M
Planet 13 Holdings
Price$0.21
Change-$0.01 (-4.55%)
Volume$264.24K
Capitalization68.84M
CRLBF vs PLNH Comparison Chart in %
Loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLNH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRLBF vs. PLNH commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRLBF is a Hold and PLNH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (CRLBF: $1.03 vs. PLNH: $0.21)
Brand notoriety: CRLBF and PLNH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRLBF: 44% vs. PLNH: 29%
Market capitalization -- CRLBF: $362.14M vs. PLNH: $68.84M
CRLBF [@Pharmaceuticals: Generic] is valued at $362.14M. PLNH’s [@Pharmaceuticals: Generic] market capitalization is $68.84M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRLBF’s FA Score shows that 0 FA rating(s) are green whilePLNH’s FA Score has 0 green FA rating(s).

  • CRLBF’s FA Score: 0 green, 5 red.
  • PLNH’s FA Score: 0 green, 5 red.
According to our system of comparison, PLNH is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRLBF’s TA Score shows that 5 TA indicator(s) are bullish while PLNH’s TA Score has 3 bullish TA indicator(s).

  • CRLBF’s TA Score: 5 bullish, 3 bearish.
  • PLNH’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CRLBF is a better buy in the short-term than PLNH.

Price Growth

CRLBF (@Pharmaceuticals: Generic) experienced а -14.17% price change this week, while PLNH (@Pharmaceuticals: Generic) price change was -6.89% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

CRLBF is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRLBF($362M) has a higher market cap than PLNH($68.8M). CRLBF YTD gains are higher at: 12.725 vs. PLNH (-44.824). CRLBF has higher annual earnings (EBITDA): 136M vs. PLNH (-9.42M). CRLBF has more cash in the bank: 147M vs. PLNH (15.9M). PLNH has less debt than CRLBF: PLNH (58.7M) vs CRLBF (631M). CRLBF has higher revenues than PLNH: CRLBF (685M) vs PLNH (117M).
CRLBFPLNHCRLBF / PLNH
Capitalization362M68.8M526%
EBITDA136M-9.42M-1,444%
Gain YTD12.725-44.824-28%
P/E RatioN/AN/A-
Revenue685M117M585%
Total Cash147M15.9M925%
Total Debt631M58.7M1,075%
FUNDAMENTALS RATINGS
CRLBF vs PLNH: Fundamental Ratings
CRLBF
PLNH
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
4465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PLNH's Valuation (42) in the null industry is somewhat better than the same rating for CRLBF (78). This means that PLNH’s stock grew somewhat faster than CRLBF’s over the last 12 months.

PLNH's Profit vs Risk Rating (100) in the null industry is in the same range as CRLBF (100). This means that PLNH’s stock grew similarly to CRLBF’s over the last 12 months.

CRLBF's SMR Rating (95) in the null industry is in the same range as PLNH (97). This means that CRLBF’s stock grew similarly to PLNH’s over the last 12 months.

CRLBF's Price Growth Rating (44) in the null industry is in the same range as PLNH (65). This means that CRLBF’s stock grew similarly to PLNH’s over the last 12 months.

CRLBF's P/E Growth Rating (100) in the null industry is in the same range as PLNH (100). This means that CRLBF’s stock grew similarly to PLNH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLBFPLNH
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 7 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLNH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOBKY15.340.19
+1.25%
Softbank Corp.
NZMEF0.35N/A
N/A
Nzme Ltd.
CIADF1.80N/A
N/A
China Mengniu Dairy Co., Ltd.
TKCBY22.95N/A
N/A
Tokai Carbon Company Ltd.
GXRFF0.03-0.01
-14.33%
Prospera Energy Inc.

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TCNNF. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
-1.90%
TCNNF - CRLBF
75%
Closely correlated
+1.09%
TSNDF - CRLBF
75%
Closely correlated
-2.69%
CURLF - CRLBF
73%
Closely correlated
-7.35%
VRNOF - CRLBF
72%
Closely correlated
-1.72%
GTBIF - CRLBF
71%
Closely correlated
-2.02%
More

PLNH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLNH has been loosely correlated with CRLBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PLNH jumps, then CRLBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLNH
1D Price
Change %
PLNH100%
-5.91%
CRLBF - PLNH
63%
Loosely correlated
-1.90%
TSNDF - PLNH
59%
Loosely correlated
-2.69%
TCNNF - PLNH
59%
Loosely correlated
+1.09%
VRNOF - PLNH
58%
Loosely correlated
-1.72%
CURLF - PLNH
57%
Loosely correlated
-7.35%
More